Related Experiment Video
Updated: Aug 27, 2026

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Hemofiltration during cardiopulmonary bypass
1Department of Anaesthesiology and Intensive Care Medicine, Hôpital Laennec, Paris. djr@invivo.edu
Insights
Cardiac surgery complications like organ failure stem from cardiopulmonary bypass (CPB). Hemofiltration during CPB may mitigate these effects by managing fluid balance and potentially reducing inflammation.
Area of Science:
- Cardiovascular Surgery
- Critical Care Medicine
- Biomedical Engineering
Background:
- Cardiac surgery, particularly with cardiopulmonary bypass (CPB), can lead to multi-organ failure.
- CPB contributes to organ dysfunction through hemodilution and triggering a systemic inflammatory response.
- The inflammatory response involves humoral factors, leading to a 'post-bypass syndrome' similar to septic shock.
Purpose of the Study:
- To explore the mechanisms behind multi-organ failure post-cardiac surgery.
- To review methods for mitigating the adverse effects of cardiac surgery and CPB.
- To investigate the role and potential benefits of hemofiltration in CPB management.
Main Methods:
- Review of existing literature on cardiac surgery complications and CPB.
- Analysis of factors contributing to postoperative organ dysfunction, including hemodilution and inflammation.
- Examination of therapeutic interventions such as hypothermia, heparin-coated circuits, and hemofiltration.
Main Results:
- CPB-induced hemodilution impairs oxygen transport, evidenced by increased transpulmonary O2 gradients and lung water.
- CPB triggers a significant inflammatory response, amplified by circuit surface area, especially in pediatric patients.
- Hemofiltration, initially used for fluid and electrolyte balance, shows promise in reducing blood loss and improving hemodynamics, with potential anti-inflammatory effects.
Conclusions:
- Multi-organ failure post-cardiac surgery is multifactorial, with CPB playing a significant role.
- Hemofiltration presents a promising adjunctive therapy during CPB to manage fluid status and potentially attenuate the inflammatory response.
- Further research is needed to elucidate the precise mechanisms by which hemofiltration exerts its beneficial effects in cardiac surgery patients.
Abstract:
Several factors combine to facilitate the evolution towards heart and multi-organ failure following cardiac surgery. Some of these factors are related to pure cardiac aspects like the existence of a preoperative heart disease, the use of aortic cross clamping or performance of cardiotomy. Cardiopulmonary bypass (CPB) also plays an important role in the occurrence of postoperative organ dysfunctions by two principal means: firstly by inducing a profound hemodilution, which impairs oxygen transport through tissues. This phenomenon is pointed out in the postoperative period by the existence of increased transpulmonary O2 gradients, extravascular lung water volume and subsequent impairments of O2 transport. Secondly CPB is deleterious by triggering an important inflammatory reaction. This reaction is largely related to the ratio of the circuit area to the patient's body surface area and is therefore maximal in children. It has been widely demonstrated that the very early paths of this reaction imply several humoral factors including kinins, coagulation factor-XII and complement fragments. The activation of these factors is self-amplified and triggers both expression and release of numerous mediators by endothelial cells and leukocytes. Finally, these mediators are responsible for the well described "post-bypass syndrome" which is, from a clinical viewpoint, very close to hyperkinetic septic shocks. Several methods have been proposed to reduce the deleterious effects of both cardiac surgery and CPB. The older one is hypothermia that considerably reduces the triggering of the inflammatory mediators network. Heparin-coated circuits may also reduce this reaction to some extent. Hemofiltration has been introduced in the 90's in CPB management. Because of its very high tolerance in patients with compromised circulatory status this technique was already used in the postoperative period to treat patients with acute renal failure. Initially hemofiltration was intended to correct the accumulation of extravascular water during or immediately following the surgical procedure. Nevertheless several of its "side-effects" appeared to be useful like reduction of postoperative blood loss and immediate hemodynamics improvement. Several studies attempted to point out the mechanism of action of hemofiltration and although removal of inflammatory mediator occurs, there is currently no proofs that this removal is the actual mechanism by which this technique acts. At the early beginning of the use of its utilization hemofiltration during cardiac surgery aimed either to concentrate blood at the end of the procedure or to rapidly restore a normal fluid and electrolytes balance. Today some new implementations of this technique are proposed either to reduce the triggering of the inflammatory reaction to CPB or to reduce the immediate postoperative drug support.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Cardiac Catheterization II: Right Heart Catheterization
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications

